BlackRock Advisors’s Novartis NVS Stock Holding History

BlackRock Advisors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$6.53M	Sell	100,084 -203,112	-67%	-$13.2M	0.01%	1036
2016 Q3	$21.5M	Buy	303,196 +203,112	+203%	+$14.8M	0.02%	498
2016 Q2	$7.4M	Hold	100,084	–	–	0.01%	950
2016 Q1	$6.5M	Hold	100,084	–	–	0.01%	988
2015 Q4	$7.72M	Sell	100,084 -404,215	-80%	-$32.1M	0.01%	954
2015 Q3	$41.5M	Buy	504,299 +39,395	+8%	+$3.51M	0.04%	333
2015 Q2	$41M	Buy	464,904 +364,820	+365%	+$33.5M	0.04%	348
2015 Q1	$8.84M	Sell	100,084 -48,323	-33%	-$4.29M	0.01%	825
2014 Q4	$12.3M	Hold	148,407	–	–	0.01%	709
2014 Q3	$12.5M	Sell	148,407 -64,313	-30%	-$5.2M	0.01%	715
2014 Q2	$17.3M	Buy	212,720 +64,313	+43%	+$5.06M	0.02%	620
2014 Q1	$11.3M	Hold	148,407	–	–	0.01%	754
2013 Q4	$10.7M	Buy	148,407 +48,323	+48%	+$3.36M	0.01%	769
2013 Q3	$6.88M	Hold	100,084	–	–	0.01%	898
2013 Q2	$6.34M	Buy	+100,084	New	+$6.51M	0.01%	896

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

BlackRock Advisors's NVS Position: Q4 2016 in Review

BlackRock Advisors reduced its Novartis (NVS) stake by 67% in Q4 2016, selling an estimated $13.2M and leaving 100,084 shares worth $6.53M. The position accounts for 0.01% of the portfolio, ranked #1036.

BlackRock Advisors first reported a position in NVS in Q2 2013 and has held it in 15 quarters since. The position peaked at $41.5M in Q3 2015. 904 funds tracked by Wall St. Rank hold NVS as of Q4 2016.

BlackRock Advisors held 100,084 shares of Novartis worth $6.53M as of Q4 2016.
BlackRock Advisors sold 203,112 Novartis shares in Q4 2016, an estimated $13.2M.
Novartis made up 0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1036 holding.
BlackRock Advisors first reported a position in Novartis in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's Novartis position peaked at $41.5M in Q3 2015.
904 funds tracked by Wall St. Rank held Novartis as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.